Use of the antifibrinolytic medication ‘narrowly exceeded’ noninferiority in VTE risk compared with placebo in noncardiac ...

WASHINGTON, DC—Administering tranexamic acid during noncardiac surgery provides a clear reduction in bleeding, with a low likelihood of harm in terms of vascular complications, the POISE-3 trial shows ...

A dose of tranexamic acid to start and end noncardiac surgery reduced important bleeding events, the POISE-3 trial showed, albeit with a question mark hanging over cardiovascular risk. The ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Tranexamic acid administered intravenously before and after noncardiac surgery lowered the risk for ...

Tranexamic acid lowers the need for transfusions for patients undergoing non-cardiac surgeries and does not increase the risk for venous thromboembolism, according to data presented at ASH Annual ...

The mismanaged care of women suffering from heavy bleeding while on their period is costing the NHS millions of pounds, ...

A new analysis has found that the mismanaged care of women who suffer from heavy bleeding while on their period is costing ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Tranexamic acid ...

Immediate treatment with tranexamic acid reduces the risk for death by 70% for people with severe bleeding, researchers say. However, rapid treatment initiation is important, as even short delays are ...

female patient hospital No significant drop in postpartum hemorrhage of 500 ml or more for women receiving oxytocin (HealthDay News) — Prophylactic administration of tranexamic acid does not reduce ...

An inexpensive and widely available drug could save the lives of one in three mothers who would otherwise bleed to death after childbirth, according to a major study published in The Lancet. The ...